Author

Jürgen Floege

0 works0 citations

Recent research

  • Health & Medicine

    Finerenone in Patients with Focal Segmental Glomerulosclerosis

    Background: Mineralocorticoid receptor overactivation is implicated in podocyte injury and glomerulosclerosis. In a prespecified analysis of the FIND-CKD trial, we examined the efficacy and safety of finerenone in participants with focal segmental glomerulosclerosis (FSGS). Metho...

    Journal of the American Society of Nephrology2026-11-150 citationsDOI